EARNEST Partners’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-29
Closed -$2.04K 295
2023
Q3
$2.04K Hold
29
﹤0.01% 992
2023
Q2
$2.31K Hold
29
﹤0.01% 975
2023
Q1
$2.1K Hold
29
﹤0.01% 984
2022
Q4
$2.39K Hold
29
﹤0.01% 974
2022
Q3
$2K Hold
29
﹤0.01% 941
2022
Q2
$2K Hold
29
﹤0.01% 957
2022
Q1
$2K Hold
29
﹤0.01% 986
2021
Q4
$2K Hold
29
﹤0.01% 998
2021
Q3
$2K Hold
29
﹤0.01% 999
2021
Q2
$2K Hold
29
﹤0.01% 1006
2021
Q1
$2K Hold
29
﹤0.01% 999
2020
Q4
$1K Hold
29
﹤0.01% 1071
2020
Q3
$1K Hold
29
﹤0.01% 1022
2020
Q2
$1K Hold
29
﹤0.01% 1003
2020
Q1
$1K Hold
29
﹤0.01% 951
2019
Q4
$1K Hold
29
﹤0.01% 1067
2019
Q3
$1K Hold
29
﹤0.01% 1051
2019
Q2
$1K Hold
29
﹤0.01% 1066
2019
Q1
$1K Hold
29
﹤0.01% 1073
2018
Q4
$1K Hold
29
﹤0.01% 1048
2018
Q3
$1K Hold
29
﹤0.01% 1086
2018
Q2
$1K Hold
29
﹤0.01% 1095
2018
Q1
$1K Hold
29
﹤0.01% 1068
2017
Q4
$1K Buy
+29
New +$1K ﹤0.01% 1066
2017
Q1
Sell
-29
Closed -$1K 235
2016
Q4
$1K Buy
+29
New +$1.13K ﹤0.01% 1008

Other funds holding ACHC

EARNEST Partners's ACHC Position: Q4 2023 in Review

EARNEST Partners sold out of Acadia Healthcare (ACHC) in Q4 2023, closing a stake of 29 shares — an estimated $2.04K sold.

EARNEST Partners first reported a position in ACHC in Q4 2016 and held it in 25 quarters. The position peaked at $2.39K in Q4 2022. 313 funds tracked by Wall St. Rank hold ACHC as of Q4 2023.

  • EARNEST Partners reported no remaining Acadia Healthcare position as of Q4 2023 after selling out during the quarter.
  • EARNEST Partners sold 29 Acadia Healthcare shares in Q4 2023, an estimated $2.04K.
  • EARNEST Partners first reported a position in Acadia Healthcare in Q4 2016 and held it in 25 quarters.
  • EARNEST Partners's Acadia Healthcare position peaked at $2.39K in Q4 2022.
  • 313 funds tracked by Wall St. Rank held Acadia Healthcare as of Q4 2023.

Based on EARNEST Partners's 13F filing for Q4 2023, filed 14 Feb 2024.